-A Bierhaus Researcher Activity Profile

Research Author Detailed Information 

A Bierhaus Publication Rate By Year

A Bierhaus has published 1 paper(s) in 1999, 1 paper(s) in 2004, 3 paper(s) in 2005, 8 paper(s) in 2007, 11 paper(s) in 2008, for a total of 24 research publications in total.

A A Bierhaus Author Information

LAST NAME: bierhaus

FIRST NAME: A

INITIALS: a

AFFILIATION:

Papers

A Bierhaus's Publication Record

1. The RAGE pathway in inflammatory myopathies and limb girdle muscular dystrophy. Year Published: 2005
2. Retinol-binding protein 4 is associated with components of the metabolic syndrome, but not with insulin resistance, in men with type 2 diabetes or coronary artery disease. Year Published: 2007
Department of Nephrology, Technical University Munich, Ismaningerstr. 22, 81675, Munich, Germany. maximilian.eynatten@lrz.tum.de
3. Improved vascular function upon pioglitazone treatment in type 2 diabetes is not associated with changes in mononuclear NF-kappaB binding activity. Year Published: 2007
Department Medicine I and Clinical Chemistry, University of Heidelberg, Im Neuenheimer Feld 410, Heidelberg, Germany.
4. The RAGE pathway in inflammatory myopathies and limb girdle muscular dystrophy. Year Published: 2005
5. sRAGE and esRAGE are not Associated with Peripheral or Autonomic Neuropathy in Type 2 Diabetes. Year Published: 2007
6. Retinol-binding protein 4 is associated with components of the metabolic syndrome, but not with insulin resistance, in men with type 2 diabetes or coronary artery disease. Year Published: 2007
Department of Nephrology, Technical University Munich, Ismaningerstr. 22, 81675, Munich, Germany. maximilian.eynatten@lrz.tum.de
7. [Non-enzymatic glycation and oxidative stress in chronic illnesses and diabetes mellitus] Year Published: 1999
8. A M55V Polymorphism in the SUMO4 Gene is Associated with a Reduced Prevalence of Diabetic Retinopathy in Patients with Type 1 Diabetes. Year Published: 2008
1Division of Endocrinology and Metabolism, Department of Medicine, University of Heidelberg, Germany.
9. sRAGE and esRAGE are not associated with peripheral or autonomic neuropathy in type 2 diabetes. Year Published: 2007
Universitätsklinikum Heidelberg Medizinische Klinik 1 und Klinische Chemie, Heidelberg, Germany. per.humpert@med.uni-heidelberg.de
10. Adult vascular progenitor cells and tissue regeneration in metabolic syndrome. Year Published: 2005
Universitätsklinikum Heidelberg, Abteilung Innere Medizin I, INF 410, Heidelberg, Germany.
11. Clinical benefit of a short term dietary oatmeal intervention in patients with type 2 diabetes and severe insulin resistance: a pilot study. Year Published: 2008
1V. Medizinische Klinik, University Hospital Mannheim, Medical Faculty Mannheim of the University of Heidelberg, Mannheim, Germany.
12. A M55V polymorphism in the SUMO4 gene is associated with a reduced prevalence of diabetic retinopathy in patients with Type 1 diabetes. Year Published: 2008
Division of Endocrinology and Metabolism, Department of Medicine, University of Heidelberg, Germany. gottfried_rudofsky@med.uni-heidelberg.de
13. Clinical benefit of a short term dietary oatmeal intervention in patients with type 2 diabetes and severe insulin resistance: a pilot study. Year Published: 2008
V Medizinische Klinik, University Hospital Mannheim, Medical Faculty Mannheim of the University of Heidelberg, Mannheim, Germany. alexander.lammert@med5.ma.uni-heidelberg.de
14. [AGE-RAGE: A Hypothesis or a Mechanism?] Year Published: 2004
15. Activated protein C protects against diabetic nephropathy by inhibiting endothelial and podocyte apoptosis. Year Published: 2007
[1] Department of Medicine I and Clinical Chemistry, University of Heidelberg, INF 410, 69120 Heidelberg, Germany. [2] These authors contributed equally to this work.
16. Activated protein C protects against diabetic nephropathy by inhibiting endothelial and podocyte apoptosis. Year Published: 2007
Department of Medicine I and Clinical Chemistry, University of Heidelberg, INF 410, 69120 Heidelberg, Germany. berend.isermann@med.uni-heidelberg.de
17. Pharmacologic cholinesterase inhibition improves survival in experimental sepsis. Year Published: 2008
Department of Anaesthesiology, University of Heidelberg, Heidelberg, Germany.
18. Pharmacologic cholinesterase inhibition improves survival in experimental sepsis. Year Published: 2008
Department of Anaesthesiology, University of Heidelberg, Heidelberg, Germany.
19. Maturing Dendritic Cells Depend on RAGE for In Vivo Homing to Lymph Nodes. Year Published: 2008
Clinical Immunology Unit.
20. Activated protein C protects against diabetic nephropathy by inhibiting endothelial and podocyte apoptosis. Year Published: 2007
Department of Medicine I and Clinical Chemistry, University of Heidelberg, INF 410, 69120 Heidelberg, Germany. berend.isermann@med.uni-heidelberg.de
21. RAGE signaling sustains inflammation and promotes tumor development. Year Published: 2008
Division of Signal Transduction and Growth Control, 2Research Group Eicosanoids and Tumor Development, and 3Division of Molecular Immunology, German Cancer Research Center, 69120 Heidelberg, Germany.
22. RAGE signaling sustains inflammation and promotes tumor development. Year Published: 2008
Division of Signal Transduction and Growth Control, German Cancer Research Center, 69120 Heidelberg, Germany.
23. Glyoxalase-1 prevents mitochondrial protein modification and enhances lifespan in Caenorhabditis elegans. Year Published: 2008
Department of Medicine I and Clinical Chemistry, University of Heidelberg, Im Neuenheimer Feld 410, 69120 Heidelberg, Germany.
24. A role for the receptor for advanced glycation end products in idiopathic pulmonary fibrosis. Year Published: 2008
Department of Pathology,University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA.